EWA
TNYA icon

EverSource Wealth Advisors’s Tenaya Therapeutics TNYA Stock Holding History

EverSource Wealth Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812 Hold
1,099
– – ﹤0.01% 4030
2026
Q1 		$761 Sell
1,099
-442
-29% -$326 ﹤0.01% 3950
2025
Q4 		$1.1K Sell
1,541
-1,088
-41% -$1.48K ﹤0.01% 3684
2025
Q3 		$4.26K Sell
2,629
-6,031
-70% -$6.07K ﹤0.01% 3227
2025
Q2 		$5.29K Buy
8,660
+6,996
+420% +$3.56K ﹤0.01% 3139
2025
Q1 		$949 Buy
+1,664
New +$1.64K ﹤0.01% 3246

Other funds holding TNYA

RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
IWS
Integrity Wealth Solutions Denver, Colorado $271M AUM 21.83% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
PWP
Parkwoods Wealth Partners Syracuse, New York $622M AUM 24.36% 1-Year Est. Return

EverSource Wealth Advisors's TNYA Position: Q2 2026 in Review

EverSource Wealth Advisors held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 1,099 shares worth $812. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

EverSource Wealth Advisors first reported a position in TNYA in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.29K in Q2 2025. 25 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • EverSource Wealth Advisors held 1,099 shares of Tenaya Therapeutics worth $812 as of Q2 2026.
  • EverSource Wealth Advisors left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4030 holding.
  • EverSource Wealth Advisors first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Tenaya Therapeutics position peaked at $5.29K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.